阿尔法-2-上腺激动剂在外部冷却过程中减少人类的休息能量消耗
Clifton W Callaway1, Katharyn L Flickinger1, Alexandra Weissman1
1Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Temperature (Austin, Tex.)
|August 28, 2024
概括
口服德克斯米德米丁和蒂桑尼丁可以降低人体的能量消耗和核心体温. 这些α-2上腺素受体激动剂,当口服时,允许体温下降,即使表面冷却.
科学领域:
- 药理学 药理学是指药理学的学科.
- 人体生理学 人体生理学
- 热调节 热调节 热调节
背景情况:
- 已知静脉注射的α-2上腺素受体激动剂可以降低人类的能量消耗和核心体温.
- 关于口服的α-2上腺素受体激动剂对温度调节和能量消耗的影响的数据有限.
研究的目的:
- 为了研究单次口服剂量德克斯梅托米丁和蒂桑尼丁与表面冷却相结合是否可以降低健康人群的能量消耗和核心体温.
主要方法:
- 26名健康参与者接受了41项实验室研究,涉及口服德克斯梅德托米丁 (舌下或吞) 或蒂扎尼丁.
- 使用摄入的遥测囊测量核心体温.
- 通过间接热量计,在摄入后长达6小时内评估了能量消耗.
主要成果:
- 德克斯梅托米丁和蒂桑尼丁都导致了能源消耗的显著峰值降低 (13%-22%相对于基线).
- 药物使用后,核心体温平均下降0.5°C~0.7°C.
- 随着核心温度的下降,能源消耗的典型补偿性增加在较高剂量的药物中减弱.
结论:
- 口服德克斯梅德托米丁和蒂扎尼丁有效地降低了人类的能量消耗.
- 这些口服药物有助于降低核心体温,特别是在与表面冷却相结合时.
- 这些发现表明,口服α-2上腺激动剂在控制温度调节方面的潜在应用.
相关概念视频
Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
Adrenergic Agonists: Therapeutic Uses
754
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
754
Adrenergic Agonists: Direct-Acting Agents
1.4K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.4K
Thermoregulation
928
The human body has a sophisticated thermoregulation system that employs negative feedback mechanisms to maintain an optimal core temperature. When the core temperature drops, peripheral and central thermoreceptors send signals to the hypothalamus, activating the heat-promoting center. This center triggers several responses aimed at increasing the core temperature. First, vasoconstriction reduces the flow of warm blood from internal organs to the skin so that the heat is not lost from the skin,...
928
Adrenergic Agonists: Mixed-Action Agents
691
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
691
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K


